Eupraxia Pharmaceuticals Inc. (EPRX)
USD 3.19
(-3.33%)
USD 3.19
(-3.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 158.37 Thousand | 142.57 Thousand | 88.17 Thousand | 91.68 Thousand | 155.72 Thousand | 92.12 Thousand |
| Gross Profit | -158.37 Thousand | -142.57 Thousand | -88.17 Thousand | -91.68 Thousand | -155.72 Thousand | -92.12 Thousand |
| Operating Expenses | 37.19 Million | 17.24 Million | 14.51 Million | 1.84 Million | 4.96 Million | 8.73 Million |
| Selling, General and Administrative Expenses | 7.28 Million | 4.28 Million | 6.64 Million | 996.54 Thousand | 2.32 Million | 3.74 Million |
| Research and Development Expenses | 27.54 Million | 12.96 Million | 7.86 Million | 849.74 Thousand | 2.64 Million | 4.99 Million |
| Other Expenses | - | - | -2.26 Million | - | 1737.00 | - |
| Cost and Expenses | 37.19 Million | 17.39 Million | 14.59 Million | 1.93 Million | 5.12 Million | 8.83 Million |
| Operating Income | -37.19 Million | -17.39 Million | -14.59 Million | -1.93 Million | -5.12 Million | -8.83 Million |
| Interest Expense | 1.17 Million | 982.85 Thousand | 1.29 Million | 1.88 Million | - | 104.09 Thousand |
| Income Tax Expense | 48.25 Thousand | -485.29 Thousand | -300.38 Thousand | -10.54 Thousand | -49.68 Thousand | -1.17 Million |
| Earnings before Tax | -38.33 Million | -17.64 Million | -18.47 Million | -3.14 Million | -5.58 Million | -10.86 Million |
| Net Income | -28.73 Million | -17.15 Million | -18.17 Million | -3.13 Million | -5.53 Million | -9.68 Million |
| Earnings Per Share Basic | -1.55 | -0.89 | -1.28 | -0.24 | -0.43 | -0.75 |
| Earnings Per Share Diluted | -1.55 | -0.89 | -1.28 | -0.24 | -0.43 | -0.75 |
| Weighted Average Shares Outstanding | 24.14 Million | 19.28 Million | 14.24 Million | 12.86 Million | 12.86 Million | 12.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.14 Million | 19.28 Million | 14.24 Million | 12.86 Million | 12.86 Million | 12.86 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -36.74 Million | -23.7 Million | -17.85 Million | -2.12 Million | -6.03 Million | -11.75 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 2.97 Million | - | - |
| Cost of Revenue | - | 37.25 Thousand | 158.37 Thousand | 1.48 Million | 36.73 Thousand | 37.1 Thousand |
| Gross Profit | - | -37.25 Thousand | -158.37 Thousand | 1.48 Million | -36.73 Thousand | -37.1 Thousand |
| Operating Expenses | 6.55 Million | 6.62 Million | 28.42 Million | 6.52 Million | 6.52 Million | 5.78 Million |
| Selling, General and Administrative Expenses | 2.58 Million | 2.49 Million | - | -199.46 Thousand | 2.01 Million | 2.19 Million |
| Research and Development Expenses | 3.97 Million | 4.13 Million | - | 6.87 Million | 4.51 Million | 3.58 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 6.55 Million | 6.66 Million | 28.58 Million | 6.52 Million | 6.56 Million | 5.82 Million |
| Operating Income | -6.15 Million | -6.66 Million | -28.58 Million | -6.34 Million | -6.56 Million | -5.82 Million |
| Interest Expense | 281.84 Thousand | 321.14 Thousand | 1.17 Million | -72.73 Thousand | 433.28 Thousand | 563.14 Thousand |
| Income Tax Expense | -5000.00 | 4977.67 | -67.65 Thousand | -291.45 Thousand | -172.43 Thousand | -130.85 Thousand |
| Earnings before Tax | -6.06 Million | -6.12 Million | -29.56 Million | -4.31 Million | -4.82 Million | -6.03 Million |
| Net Income | -6 Million | -6.01 Million | -28.73 Million | -4.09 Million | -4.64 Million | -5.9 Million |
| Earnings Per Share Basic | -0.17 | -0.21 | - | -0.15 | -0.18 | -0.27 |
| Earnings Per Share Diluted | -0.17 | -0.21 | - | -0.15 | -0.18 | -0.27 |
| Weighted Average Shares Outstanding | 35.62 Million | 28.81 Million | 24.14 Million | 27.3 Million | 25.52 Million | 22 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.62 Million | 28.81 Million | 24.14 Million | 27.3 Million | 25.52 Million | 22 Million |
| Gross Margin | - | - | - | 0.50 | - | - |
| EBIT Margin | - | - | - | -2.13 | - | - |
| Profit Margin | - | - | - | -1.38 | - | - |
| EBITDA | -6.11 Million | -6.62 Million | - | -6.34 Million | -6.52 Million | -5.78 Million |
| Earnings Before Tax Margin | - | - | - | -2.13 | - | - |
GLB
000716
MCBS
TRU
ISS
002542